A Web-based Digital Distance Visual Acuity Test

Refractive Errors Clinical Trial

— DDVIT  

Official title:

Development and Validation of a Web-based Digital Distance Visual Acuity Test

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04756596
• Other study ID #: ES1/Th6/21-1-2021
• Status: Recruiting
• Start date: February 1, 2021
• Est. completion date: June 30, 2022

Study information

• Verified date: November 2021
• Source: Democritus University of Thrace
• Contact: Georgios Labiris, MD, PhD
• Phone: 00302551030405
• Email: labiris[@]usa.net
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

Primary objective of this study is the development and validation of a web-based application for the examination of the distance visual acuity of normal- and low-vision patients.

Description:

Present study aims to develop and validate a web-based digital distance visual acuity test (Democritus Distance Vision Test - DDVIT). DDVIT is an application, which will be easily accessed through a simple internet connection. This application will provide the possibility of a simple but reliable examination of patients, establishing a commonly accepted way of measuring the distance visual acuity among rural doctors, general practitioners and ophthalmologists. Specifically, present study aims to develop a new online distance visual acuity test (DDVIT) according to the standards of the Early Treatment Diabetic Retinopathy Study (ETDRS) test and to evaluate the level of agreement between the two visual acuity tests, as well as the test-retest reliability of the online DDVIT visual acuity test. The first part of the study is the development of the online visual acuity test (letters, numbers, symbols) including the following smart features: 1. Adjustment of the font size according to the size of the computer screen used for the examination 2. Real time calculation of the patient-screen distance through a face detection system 3. Automatic calculation of the reading time of each line (each logMAR) 4. Entering the number of patient's reading errors for each line 5. Automatic calculation of the visual acuity in the following score units: - Number of Letters (max 85) - Visual Acuity Score (max 100) - logMAR - Decimal - Snellen Fraction The calculation of various reading parameters resulting from the aforementioned features (visual acuity score in different units, reading duration (in sec) and number of errors for each slide (line), patient-screen distance for each slide) will be performed after the end of the examination. Except for the html format, a file in the format of Microsoft Excel and Pdf are also generated. The second part of this study is the clinical validation of the DDVIT visual acuity test. In this part, the reading acuity measured with the DDVIT and ETDRS test are compared. All the comparisons will take place in two groups: a) a Normal Vision Group (NVG), and b) a Low Vision Group (LVG) in order to estimate the visual acuity in a population with a wide range of vision.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 300
• Est. completion date: June 30, 2022
• Est. primary completion date: May 31, 2022
• Gender: All
• Age group: 18 Years to 75 Years

Eligibility

Inclusion Criteria:

• Patients of our outpatient ophthalmology clinic
• Age between 18 to 75 years

Exclusion Criteria:

• Dyslexia
• Attention-deficiency
• Former diagnosis of mental and/or psychiatric diseases
• Inability to cooperate

Related Conditions & MeSH terms

• Low Vision
• Refractive Errors
• Vision Disorders
• Vision, Low

Intervention

Diagnostic Test:
• DDVIT testing
One randomly selected eye will be included for each study participant. Participants respond to the DDVIT test in standard environmental lighting conditions at 4 m viewing distance. Visual acuity will be evaluated.
• ETDRS testing
The same eye is included for each study participant. Participants respond to the standard ETDRS chart of our Ophthalmology Department in standard environmental lighting conditions at 4 m viewing distance. Visual acuity will be evaluated.

Locations

Country	Name	City	State
Greece	Department of Ophthalmology, University Hospital of Alexandroupolis	Alexandroupolis	Evros
Greece	Department of Computer Science and Biomedical Informatics, University of Thessaly	Lamía	Thessaly

Sponsors (2)

Lead Sponsor	Collaborator
Democritus University of Thrace	University of Thessaly

Country where clinical trial is conducted

Greece, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Distance visual acuity using DDVIT vision test	The distance visual acuity of the one randomly selected eye of each participant will be evaluated by the examiner using DDVIT vision test.	4 months
Primary	Distance visual acuity using ETDRS vision test	The distance visual acuity of the same eye of each participant will be evaluated by the same examiner using the web-based ETDRS vision test under the same predetermined environmental lighting conditions.	4 months